secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001104659-25-005659
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phibro Animal Health appoints Joyce J. Lee to board as independent director
---------------------------------------------------------------------------

- Joyce J. Lee appointed as Class II independent director effective January 21, 2025, filling a vacancy.
- Board expands to nine directors, six of whom are independent.
- Ms. Lee most recently served as President of Cobb Vantress; prior exec roles at Elanco, Bayer Animal Health, Zoetis.
- She will receive standard non-employee director compensation and has entered a director indemnification agreement.
- Ms. Lee is expected to stand for election at the 2027 Annual Meeting of Stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000110465925005659/0001104659-25-005659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000110465925005659/tm254181d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-005659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer